{
  "meta": {
    "title": "17_Amyloidosis_And_Graft_Rejection",
    "url": "https://brainandscalpel.vercel.app/17-amyloidosis-and-graft-rejection-b760a8e3.html",
    "scrapedAt": "2025-11-30T12:33:27.171Z"
  },
  "questions": [
    {
      "text": "Which among the following best describes an amyloid?",
      "choices": [
        {
          "id": 1,
          "text": "Colloid"
        },
        {
          "id": 2,
          "text": "Lipoprotein"
        },
        {
          "id": 3,
          "text": "Proteoglycan"
        },
        {
          "id": 4,
          "text": "Intermediate filament"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Amyloid</strong> can be best described as a&nbsp;<strong>proteoglycan.</strong></p>\n<p><strong>Amyloidosis</strong> refers to the&nbsp;<strong>extracellular deposition</strong>&nbsp;of<strong> fibrillar proteins.&nbsp;</strong></p>\n<p>Abnormal fibrils are produced by the aggregation of misfolded proteins. The fibrillar deposits bind a wide variety of <strong>proteoglycans</strong> and <strong>glycosaminoglycans&nbsp;</strong>(heparan sulfate and dermatan sulfate), and plasma proteins (serum amyloid P component).</p>\n<p>The abundant charged sugar groups in these adsorbed proteins give the deposits staining characteristics that resemble starch <strong>(amylose).&nbsp;</strong>Therefore, these deposits are called amyloid.</p>\n<p>Amyloid appears as an <strong>amorphous, eosinophilic, hyaline, extracellular </strong>substance.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2458",
      "difficulty": "medium"
    },
    {
      "text": "In a patient with reactive systemic amyloidosis, which of the following proteins are likely to get deposited in the tissues?",
      "choices": [
        {
          "id": 1,
          "text": "Aβ"
        },
        {
          "id": 2,
          "text": "AL"
        },
        {
          "id": 3,
          "text": "AA"
        },
        {
          "id": 4,
          "text": "APrP"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>There is the deposition of <strong>AA proteins </strong>in <strong>reactive systemic amyloidosis</strong> (secondary amyloidosis).</p>\n<p>In <strong>inflammatory </strong>states, there is&nbsp;a release of <strong>IL-1</strong> and<strong> IL-6,</strong>&nbsp;which act on the liver cells. The liver increases the production of <strong>SAA </strong>(serum amyloid-associated)<strong> proteins</strong>&nbsp;which circulate bound to<strong> high-density lipoproteins</strong>. This gives rise to<strong> AA proteins</strong>, which get <strong>deposited in tissues</strong> causing reactive systemic amyloidosis or secondary amyloidosis.</p>\n<p>The most common <strong>sites</strong> are the&nbsp;<strong>kidney</strong> and <strong>heart.</strong></p>\n<p>It is usually seen secondary to:</p>\n<ul>\n<li>Rheumatoid arthritis (most common)</li>\n<li>Tuberculosis</li>\n<li>Bronchiectasis</li>\n<li>Chronic osteomyelitis</li>\n<li>Inflammatory bowel disease</li>\n<li>Ankylosing spondylitis</li>\n<li>Malignancies - renal cell cancer,&nbsp;Hodgkin&rsquo;s lymphoma</li>\n</ul><hr><h3>Related Pearl: Classification of Amyloidosis</h3><div class=\"page\" title=\"Page 270\">\n<table><colgroup><col /><col /><col /><col /> </colgroup>\n<tbody>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Clinicopathologic Category</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Major Fibril Protein</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Chemically Related Precursor Protein</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Systemic (Generalized) Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Immunoglobulin light chain amyloidosis (<strong>primary amyloidosis</strong>)</p>\n<p>Seen in Multiple myeloma and other monoclonal plasma cell proliferation</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AL</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Immunoglobulin light chains, chiefly &lambda; type</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Reactive systemic amyloidosis (<strong>secondary amyloidosis</strong>)</p>\n<p>Seen in chronic inflammatory conditions</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AA</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>SAA</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Hemodialysis-associated amyloidosis</p>\n<p>Seen in chronic renal failure</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A&beta;2m</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&beta;2-microglobulin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Hereditary Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Familial Mediterranean fever</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AA</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>SAA</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Familial amyloidotic neuropathies</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ATTR</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mutated transthyretin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Systemic senile amyloidosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ATTR</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Normal transthyretin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Localized Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Senile cerebral amyloidosis</p>\n<p>Seen in Alzheimer's disease</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A&beta;</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>APP</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Endocrine disorders like Type 2 diabetes</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Medullary carcinoma thyroid</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A Cal</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Calcitonin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Islets of Langerhans</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AIAPP</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Islet amyloid peptide</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Isolated atrial amyloidosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AANF</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Atrial natriuretic factor</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2500",
      "difficulty": "medium"
    },
    {
      "text": "What is the most common cause of reactive amyloidosis worldwide?",
      "choices": [
        {
          "id": 1,
          "text": "Rheumatoid arthritis"
        },
        {
          "id": 2,
          "text": "Multiple myeloma"
        },
        {
          "id": 3,
          "text": "Crohn's disease"
        },
        {
          "id": 4,
          "text": "Diabetes mellitus"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>most common cause</strong> of <strong>reactive&nbsp;amyloidosis</strong> worldwide is&nbsp;<strong>rheumatoid arthritis.</strong></p>\n<p>Amyloidosis is reported to occur in 3% of patients with rheumatoid arthritis and is clinically significant in one-half of those affected.</p>\n<p>Conditions associated with reactive systemic (<strong>secondary</strong>) <strong>amyloidosis</strong>:</p>\n<ul>\n<li>Rheumatoid arthritis (most common)</li>\n<li>Ankylosing spondylitis</li>\n<li>Inflammatory bowel disease (Crohn's disease and ulcerative colitis)</li>\n<li>Tuberculosis&nbsp;</li>\n<li>Bronchiectasis</li>\n<li>Chronic osteomyelitis</li>\n<li>Malignancies - renal cell cancer,&nbsp;Hodgkin&rsquo;s lymphoma</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2753",
      "difficulty": "medium"
    },
    {
      "text": "An elderly woman is brought with worsening memory for the past 3 years. Recently, she has been unable to carry out her daily chores and frequently gets lost in the neighborhood. There is no history of personality changes, rigidity, or gait disturbances. MRI brain shows temporal lobe atrophy. Which of the following deposits is likely to be seen in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Aβ2m amyloid"
        },
        {
          "id": 2,
          "text": "Aβ amyloid"
        },
        {
          "id": 3,
          "text": "ATTR amyloid"
        },
        {
          "id": 4,
          "text": "AIAPP amyloid"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of&nbsp;<strong>Alzheimer's</strong> disease.&nbsp;<strong>A&beta;</strong>&nbsp;<strong>amyloid</strong>&nbsp;deposition is seen in this condition.</p>\n<p>A&beta;&nbsp;constitutes the core of <strong>cerebral plaques</strong>&nbsp;found in <strong>Alzheimer's disease.&nbsp;</strong>It also gets deposited in the walls of cerebral blood vessels.&nbsp;The A&beta; protein is derived by proteolysis from a much larger transmembrane glycoprotein, called <strong>amyloid precursor protein</strong> (APP).</p><hr><h3>Related Pearl: Classification of Amyloidosis</h3><div class=\"page\" title=\"Page 270\">\n<table><colgroup><col /><col /><col /><col /> </colgroup>\n<tbody>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Clinicopathologic Category</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Major Fibril Protein</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Chemically Related Precursor Protein</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Systemic (Generalized) Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Immunoglobulin light chain amyloidosis (<strong>primary amyloidosis</strong>)</p>\n<p>Seen in Multiple myeloma and other monoclonal plasma cell proliferation</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AL</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Immunoglobulin light chains, chiefly &lambda; type</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Reactive systemic amyloidosis (<strong>secondary amyloidosis</strong>)</p>\n<p>Seen in chronic inflammatory conditions</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AA</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>SAA</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Hemodialysis-associated amyloidosis</p>\n<p>Seen in chronic renal failure</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A&beta;2m</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&beta;2-microglobulin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Hereditary Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Familial Mediterranean fever</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AA</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>SAA</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Familial amyloidotic neuropathies</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ATTR</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mutated transthyretin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Systemic senile amyloidosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ATTR</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Normal transthyretin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Localized Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Senile cerebral amyloidosis</p>\n<p>Seen in Alzheimer's disease</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A&beta;</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>APP</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Endocrine disorders like Type 2 diabetes</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Medullary carcinoma thyroid</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A Cal</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Calcitonin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Islets of Langerhans</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AIAPP</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Islet amyloid peptide</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Isolated atrial amyloidosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AANF</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Atrial natriuretic factor</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2501",
      "difficulty": "easy"
    },
    {
      "text": "A diabetic patient with chronic kidney disease has been undergoing hemodialysis for the past 4 years. Deposition of which of the following is likely in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "α1 microglobulin"
        },
        {
          "id": 2,
          "text": "β2 microglobulin"
        },
        {
          "id": 3,
          "text": "α2 macroglobulin"
        },
        {
          "id": 4,
          "text": "γ globulin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Patients on <strong>long-term hemodialysis</strong> for renal failure can develop <strong>amyloidosis</strong> as a result of the&nbsp;<strong>deposition</strong> of<strong> &beta;2-microglobulin</strong>.</p>\n<p>This protein is present in high concentrations in the serum of persons with renal disease.&nbsp;The protein is retained in the circulation because it cannot be filtered through the dialysis membranes.</p>\n<p>It gets deposited in the <strong>synovium, joints,</strong> and <strong>tendon sheaths.</strong> When this deposition takes place in the carpal ligament of the wrist, it leads to the development of&nbsp;<strong>carpal tunnel syndrome.</strong></p>\n<p>With new dialysis filters, the incidence of this complication has decreased substantially.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2507",
      "difficulty": "easy"
    },
    {
      "text": "Which type of amyloidosis is caused by the mutation of the transthyretin protein?",
      "choices": [
        {
          "id": 1,
          "text": "Familial Mediterranean fever"
        },
        {
          "id": 2,
          "text": "Familial amyloidotic polyneuropathy"
        },
        {
          "id": 3,
          "text": "Systemic senile amyloidosis"
        },
        {
          "id": 4,
          "text": "Reactive systemic amyloidosis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Familial amyloidotic polyneuropathy&nbsp;</strong>(FAP) is&nbsp;associated&nbsp;with the deposition of&nbsp;<strong>mutant transthyretin</strong> protein (TTR).<strong>&nbsp;</strong></p>\n<p>FAP is an <strong>autosomal dominant</strong>&nbsp;condition. The deposition occurs as <strong>amyloid</strong> <strong>fibrils</strong> in peripheral and autonomic nerves. Mutated TTR is prone to misfolding and aggregation, and shows resistance to proteolysis.</p>\n<p><strong>Systemic senile amyloidosis </strong>(amyloid of aging) refers to the systemic deposition of <strong>normal TTR&nbsp;</strong>amyloid in elderly patients. Symptomatic patients present with restrictive cardiomyopathy and arrhythmias. Another rare form affecting&nbsp;predominantly the heart results from the deposition of a mutant form of TTR.</p>\n<p><strong>Familial Mediterranean fever</strong> (FMF) is an&nbsp;<strong>autosomal-recessive&nbsp;</strong>condition seen in individuals of Mediterranean descent (Armenian, Sephardic Jewish, and Arabic). The affected gene encodes a protein called <strong>pyrin,&nbsp;</strong>which is involved in cytokine production. The <strong>amyloid</strong> fibril proteins in this condition are made up of <strong>AA proteins.&nbsp;</strong>It presents with attacks of fever and serositis.&nbsp;</p>\n<p><strong>Isolated atrial amyloidosis&nbsp;</strong>is associated with AANP (atrial natriuretic peptide) amyloid deposition</p><hr><h3>Related Pearl: Classification of Amyloidosis</h3><div class=\"page\" title=\"Page 270\">\n<table><colgroup><col /><col /><col /><col /> </colgroup>\n<tbody>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Clinicopathologic Category</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Major Fibril Protein</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Chemically Related Precursor Protein</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Systemic (Generalized) Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Immunoglobulin light chain amyloidosis (<strong>primary amyloidosis</strong>)</p>\n<p>Seen in Multiple myeloma and other monoclonal plasma cell proliferation</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AL</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Immunoglobulin light chains, chiefly &lambda; type</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Reactive systemic amyloidosis (<strong>secondary amyloidosis</strong>)</p>\n<p>Seen in chronic inflammatory conditions</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AA</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>SAA</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Hemodialysis-associated amyloidosis</p>\n<p>Seen in chronic renal failure</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A&beta;2m</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&beta;2-microglobulin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Hereditary Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Familial Mediterranean fever</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AA</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>SAA</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Familial amyloidotic neuropathies</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ATTR</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mutated transthyretin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Systemic senile amyloidosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ATTR</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Normal transthyretin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Localized Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Senile cerebral amyloidosis</p>\n<p>Seen in Alzheimer's disease</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A&beta;</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>APP</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Endocrine disorders like Type 2 diabetes</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Medullary carcinoma thyroid</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A Cal</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Calcitonin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Islets of Langerhans</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AIAPP</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Islet amyloid peptide</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Isolated atrial amyloidosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AANF</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Atrial natriuretic factor</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2515",
      "difficulty": "medium"
    },
    {
      "text": "Who among the following patients is at increased risk for developing amyloidosis?",
      "choices": [
        {
          "id": 1,
          "text": "A patient with maturity-onset diabetes of the young"
        },
        {
          "id": 2,
          "text": "A 15-year-old diabetic boy who is on insulin therapy"
        },
        {
          "id": 3,
          "text": "A 50-year-old diabetic patient with insulin resistance"
        },
        {
          "id": 4,
          "text": "A patient with autosomal dominant non-insulin dependent form of diabetes"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Older individuals with insulin resistance are likely to have&nbsp;<strong>type 2</strong>&nbsp;<strong>diabetes mellitus</strong>. These patients are at <strong>increased risk</strong> of developing&nbsp;<strong>amyloidosis</strong>.<strong>&nbsp;</strong></p>\n<p>Microscopic deposits of localized amyloid may be found in certain conditions such as:</p>\n<ul>\n<li><strong>Medullary carcinoma</strong> of the thyroid gland</li>\n<li>Islet tumors of the pancreas</li>\n<li><strong>Pheochromocytomas</strong></li>\n<li>Undifferentiated <strong>carcinomas</strong> of the <strong>stomach</strong></li>\n<li>Islets of Langerhans in individuals with <strong>type 2 diabetes mellitus</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2328",
      "difficulty": "medium"
    },
    {
      "text": "A middle-aged woman presents with thyroid swelling. The histological examination of the swelling is shown below. What type of amyloid deposits are seen in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "A Cal"
        },
        {
          "id": 2,
          "text": "Aβ2m"
        },
        {
          "id": 3,
          "text": "AL"
        },
        {
          "id": 4,
          "text": "Aβ"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The slide is showing the presence of&nbsp;<strong>amyloid-rich stroma</strong>&nbsp;(pinkish material) and nests of polygonal cells, suggestive of <strong>medullary carcinoma thyroid. </strong>The major fibril protein&nbsp;that gets deposited is<strong> A Cal,</strong> which is derived from <strong>calcitonin</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6577164b622f423b80a57a1138ceffeex1280x1050.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/daaf0899043c4cd2bf648aae2e7d2fb5x1280x1050.JPEG\" alt=\"Explanation Image\"><p>Microscopic deposits of <strong>localized</strong> <strong>amyloid</strong> may be found in certain conditions such as:</p>\n<ul>\n<li><strong>Medullary carcinoma</strong> of the thyroid gland</li>\n<li>Islet tumors of the pancreas</li>\n<li><strong>Pheochromocytomas</strong></li>\n<li>Undifferentiated <strong>carcinomas</strong> of the <strong>stomach</strong></li>\n<li>Islets of Langerhans in individuals with <strong>type 2 diabetes mellitus</strong></li>\n</ul><hr><h3>Related Pearl: Classification of Amyloidosis</h3><div class=\"page\" title=\"Page 270\">\n<table><colgroup><col /><col /><col /><col /> </colgroup>\n<tbody>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Clinicopathologic Category</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Major Fibril Protein</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Chemically Related Precursor Protein</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Systemic (Generalized) Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Immunoglobulin light chain amyloidosis (<strong>primary amyloidosis</strong>)</p>\n<p>Seen in Multiple myeloma and other monoclonal plasma cell proliferation</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AL</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Immunoglobulin light chains, chiefly &lambda; type</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Reactive systemic amyloidosis (<strong>secondary amyloidosis</strong>)</p>\n<p>Seen in chronic inflammatory conditions</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AA</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>SAA</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Hemodialysis-associated amyloidosis</p>\n<p>Seen in chronic renal failure</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A&beta;2m</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&beta;2-microglobulin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Hereditary Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Familial Mediterranean fever</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AA</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>SAA</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Familial amyloidotic neuropathies</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ATTR</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mutated transthyretin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Systemic senile amyloidosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ATTR</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Normal transthyretin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Localized Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Senile cerebral amyloidosis</p>\n<p>Seen in Alzheimer's disease</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A&beta;</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>APP</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Endocrine disorders like Type 2 diabetes</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Medullary carcinoma thyroid</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A Cal</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Calcitonin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Islets of Langerhans</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AIAPP</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Islet amyloid peptide</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Isolated atrial amyloidosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AANF</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Atrial natriuretic factor</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/78b138cfc2d34f9d8f1c817638a23c2d.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0230",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is the most common organ involved in AL amyloidosis?",
      "choices": [
        {
          "id": 1,
          "text": "Cardiac tissue"
        },
        {
          "id": 2,
          "text": "Renal tissue"
        },
        {
          "id": 3,
          "text": "Splenic tissue"
        },
        {
          "id": 4,
          "text": "Hepatic tissue"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>most common</strong> organ involved in AL amyloidosis is <strong>renal tissue</strong> (Kidneys). They are affected in 70&ndash;80% of patients with <strong>amyloidosis.</strong></p>\n<p><strong>Heart</strong> is the <strong>second most commonly</strong> affected organ (50&ndash;60%), and cardiac involvement is the <strong>leading cause</strong> of <strong>death</strong> from <strong>AL amyloidosis.</strong>&nbsp;</p>\n<p>Renal amyloidosis usually manifests as proteinuria, often in the nephrotic range, and is associated with hypoalbuminemia, secondary hypercholesterolemia, hypertriglyceridemia, and&nbsp;edema or anasarca.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4d53e868970141db984b159701708b15x1280x1060.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2521",
      "difficulty": "medium"
    },
    {
      "text": "A bone marrow examination is being planned for a patient with AL amyloidosis. Which of the following is likely to be seen?",
      "choices": [
        {
          "id": 1,
          "text": "Plasmacytosis"
        },
        {
          "id": 2,
          "text": "Dry tap"
        },
        {
          "id": 3,
          "text": "Fibrosis"
        },
        {
          "id": 4,
          "text": "Granulomatous reaction"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Bone marrow</strong>&nbsp;examination in<strong> AL amyloidosis</strong> shows <strong>plasmacytosis.</strong></p>\n<p>The AL&nbsp;type of amyloid or <strong>primary amyloidosis</strong> is associated with immunocyte dyscrasias like<strong> multiple myeloma </strong>or other<strong> B cell neoplasms</strong>. The tumor cells in multiple myeloma secrete light chains of the immunoglobulins of either<strong>&nbsp;the lambda or kappa</strong> type, which get deposited in the tissues as amyloid.</p>\n<p>The chemical nature of the amyloid is AL (<strong>A </strong>for <strong>amyloid</strong> and<strong> L </strong>for <strong>light chain</strong>).</p><hr><h3>Related Pearl: Classification of Amyloidosis</h3><div class=\"page\" title=\"Page 270\">\n<table><colgroup><col /><col /><col /><col /> </colgroup>\n<tbody>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Clinicopathologic Category</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Major Fibril Protein</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Chemically Related Precursor Protein</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Systemic (Generalized) Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Immunoglobulin light chain amyloidosis (<strong>primary amyloidosis</strong>)</p>\n<p>Seen in Multiple myeloma and other monoclonal plasma cell proliferation</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AL</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Immunoglobulin light chains, chiefly &lambda; type</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Reactive systemic amyloidosis (<strong>secondary amyloidosis</strong>)</p>\n<p>Seen in chronic inflammatory conditions</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AA</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>SAA</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Hemodialysis-associated amyloidosis</p>\n<p>Seen in chronic renal failure</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A&beta;2m</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&beta;2-microglobulin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Hereditary Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Familial Mediterranean fever</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AA</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>SAA</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Familial amyloidotic neuropathies</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ATTR</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mutated transthyretin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Systemic senile amyloidosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ATTR</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Normal transthyretin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Localized Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Senile cerebral amyloidosis</p>\n<p>Seen in Alzheimer's disease</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A&beta;</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>APP</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Endocrine disorders like Type 2 diabetes</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Medullary carcinoma thyroid</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A Cal</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Calcitonin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Islets of Langerhans</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AIAPP</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Islet amyloid peptide</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Isolated atrial amyloidosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AANF</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Atrial natriuretic factor</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2494",
      "difficulty": "medium"
    },
    {
      "text": "In lardaceous spleen, deposition of amyloid occurs in which of the following sites?",
      "choices": [
        {
          "id": 1,
          "text": "Sinusoids of red pulp"
        },
        {
          "id": 2,
          "text": "White pulp"
        },
        {
          "id": 3,
          "text": "Splenic follicles"
        },
        {
          "id": 4,
          "text": "Splenic capsule"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Lardaceous spleen</strong> is due to the deposition of amyloid in <strong>sinusoids</strong> of the&nbsp;<strong>red pulp.</strong></p>\n<p><strong>Sago spleen&nbsp;</strong>is due to the deposition of amyloid in splenic&nbsp;<strong>follicles (white pulp).</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2522",
      "difficulty": "easy"
    },
    {
      "text": "Match the following.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Condition</strong></td>\n<td colspan=\"2\"><strong>Amyloid protein</strong></td>\n</tr>\n<tr>\n<td>1.</td>\n<td>Familial Mediterranean fever</td>\n<td>a.</td>\n<td>A&beta;</td>\n</tr>\n<tr>\n<td>2.</td>\n<td>Alzheimer's disease</td>\n<td>b.</td>\n<td>A&beta;2m</td>\n</tr>\n<tr>\n<td>3.</td>\n<td>Systemic senile amyloidosis</td>\n<td>c.</td>\n<td>AA</td>\n</tr>\n<tr>\n<td>4.</td>\n<td>Hemodialysis-associated amyloidosis</td>\n<td>d.</td>\n<td>ATTR</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-b,  2-c, 3-a, 4-d"
        },
        {
          "id": 2,
          "text": "1-a,  2-d, 3-b, 4-c"
        },
        {
          "id": 3,
          "text": "1-c,  2-a, 3-d, 4-b"
        },
        {
          "id": 4,
          "text": "1-d,  2-b, 3-c, 4-a"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The correct match is:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Condition</strong></td>\n<td><strong>Amyloid protein</strong></td>\n</tr>\n<tr>\n<td>Familial Mediterranean fever</td>\n<td>AA</td>\n</tr>\n<tr>\n<td>Alzheimer's disease</td>\n<td>A&beta;</td>\n</tr>\n<tr>\n<td>Systemic senile amyloidosis</td>\n<td>ATTR</td>\n</tr>\n<tr>\n<td>Hemodialysis-associated amyloidosis</td>\n<td>A&beta;2m</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Classification of Amyloidosis</h3><div class=\"page\" title=\"Page 270\">\n<table><colgroup><col /><col /><col /><col /> </colgroup>\n<tbody>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Clinicopathologic Category</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Major Fibril Protein</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Chemically Related Precursor Protein</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Systemic (Generalized) Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Immunoglobulin light chain amyloidosis (<strong>primary amyloidosis</strong>)</p>\n<p>Seen in Multiple myeloma and other monoclonal plasma cell proliferation</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AL</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Immunoglobulin light chains, chiefly &lambda; type</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Reactive systemic amyloidosis (<strong>secondary amyloidosis</strong>)</p>\n<p>Seen in chronic inflammatory conditions</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AA</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>SAA</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Hemodialysis-associated amyloidosis</p>\n<p>Seen in chronic renal failure</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A&beta;2m</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&beta;2-microglobulin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Hereditary Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Familial Mediterranean fever</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AA</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>SAA</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Familial amyloidotic neuropathies</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ATTR</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mutated transthyretin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Systemic senile amyloidosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ATTR</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Normal transthyretin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Localized Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Senile cerebral amyloidosis</p>\n<p>Seen in Alzheimer's disease</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A&beta;</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>APP</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Endocrine disorders like Type 2 diabetes</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Medullary carcinoma thyroid</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A Cal</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Calcitonin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Islets of Langerhans</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AIAPP</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Islet amyloid peptide</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Isolated atrial amyloidosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AANF</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Atrial natriuretic factor</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2752",
      "difficulty": "easy"
    },
    {
      "text": "In a patient with suspected systemic amyloidosis, which of the following is the initial investigation of choice?",
      "choices": [
        {
          "id": 1,
          "text": "Kidney biopsy"
        },
        {
          "id": 2,
          "text": "Abdominal fat staining"
        },
        {
          "id": 3,
          "text": "Bone marrow aspiration"
        },
        {
          "id": 4,
          "text": "Rectal biopsy"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In suspected <strong>systemic amyloidosis,</strong> the initial investigation of choice is&nbsp;<strong>abdominal fat aspirate staining.</strong></p>\n<p><strong>Diagnosis</strong> of amyloidosis involves the following:</p>\n<ul>\n<li><strong>Localized</strong> amyloidosis - biopsy the organ involved. e.g., kidney</li>\n<li><strong>Systemic</strong> amyloidosis - deposits can be found in any tissue of the body\n<ul>\n<li>Initial test - <strong>non-invasive</strong> test on easily accessible tissue (eg:&nbsp;<strong>abdominal fat</strong>) which is positive in &gt;80% of cases</li>\n<li>If this is <strong>negative</strong>&nbsp;- more <strong>invasive biopsies</strong> of the kidney, heart, lung or GI tract (rectal biopsy)&nbsp;</li>\n</ul>\n</li>\n<li><strong>Suspected AL</strong> amyloidosis - serum and urine <strong>electrophoresis</strong> and immunoelectrophoresis&nbsp;</li>\n</ul>\n<p>The <strong>histological examination</strong> of the biopsy material is the commonest <strong>confirmatory</strong> method for the diagnosis in a suspected case of amyloidosis. <span data-preserver-spaces=\"true\">The next best step is to determine the <strong>type</strong> of <strong>precursor protein</strong> by&nbsp;</span><strong><span data-preserver-spaces=\"true\">immunohistochemistry</span></strong><span data-preserver-spaces=\"true\">, immunoelectron microscopy, or extraction and biochemical analysis employing mass spectrometry.</span></p>\n<p><strong>Scintigraphy</strong> with <strong>radiolabeled </strong>serum amyloid P component is a rapid and specific test, which gives the extent of the disease. It can be used to follow up on patients undergoing treatment.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2519",
      "difficulty": "easy"
    },
    {
      "text": "A kidney biopsy sample is obtained from a patient with high suspicion of amyloidosis. All of the following can be used to stain this sample, except:",
      "choices": [
        {
          "id": 1,
          "text": "Thioflavin"
        },
        {
          "id": 2,
          "text": "Crystal violet"
        },
        {
          "id": 3,
          "text": "Iodine"
        },
        {
          "id": 4,
          "text": "Sudan black"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Sudan Black</strong> is used for staining<strong> lipids,&nbsp;</strong>not amyloid.</p>\n<p>Staining for<strong> amyloid:</strong></p>\n<ul>\n<li><strong>Congo red</strong>&nbsp;- most widely used&nbsp;and specific&nbsp;</li>\n<li><strong>Iodine</strong> staining -\n<ul>\n<li>Used <strong>for unfixed specimens</strong> or histological sections</li>\n<li>Amyloid stains <strong>mahogany brown</strong> and <strong>turns</strong> <strong>violet&nbsp;</strong>on adding sulfuric acid</li>\n</ul>\n</li>\n<li><strong>Thioflavin T </strong>and<strong> S</strong>&nbsp;-\n<ul>\n<li>Secondary immunofluorescence with ultraviolet light</li>\n<li>Thioflavin T is useful for demonstrating the&nbsp;juxtaglomerular apparatus of the kidney</li>\n</ul>\n</li>\n<li>Metachromatic stains (<strong>crystal violet</strong> and methyl violet) -&nbsp;<strong>rose-pink</strong> appearance.</li>\n<li>Periodic-acid Schiff (<strong>PAS</strong>)<strong> positive</strong></li>\n</ul>\n<p>The image given below shows the amyloid appearance on congo red under plain microscopy.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/07bfaaf781bc40048c283f4613e412a1x1280x1078.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Appearance of Amyloid</h3><table>\n<tbody>\n<tr>\n<td><strong>Methods</strong></td>\n<td><strong>Appearance</strong></td>\n</tr>\n<tr>\n<td>On light microscopy and standard tissue stains&nbsp;(H&amp;E)&nbsp;</td>\n<td>Amorphous eosinophilic extracellular substance&nbsp;</td>\n</tr>\n<tr>\n<td>Congo red stain on ordinary light&nbsp;&nbsp;&nbsp;</td>\n<td>Pink or red&nbsp;colour&nbsp;to tissue deposits&nbsp;</td>\n</tr>\n<tr>\n<td>Congo red stain on polarizing microscopy&nbsp;&nbsp;</td>\n<td>Apple-green birefringence&nbsp;</td>\n</tr>\n<tr>\n<td>Fluorescent stains (thioflavin T and S)&nbsp;&nbsp;&nbsp;</td>\n<td>Yellow&nbsp;colour&nbsp;under UV light&nbsp;</td>\n</tr>\n<tr>\n<td>Electron microscopy&nbsp;</td>\n<td>Nonbranching fibrils of indefinite length and a&nbsp;diameter of approximately 7.5 to 10 nm.&nbsp;</td>\n</tr>\n<tr>\n<td>X-ray crystallography and infrared spectroscopy&nbsp;</td>\n<td>Characteristic cross &beta; pleated sheet conformation&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>H&amp;E: Hematoxylin and eosin &nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2493",
      "difficulty": "medium"
    },
    {
      "text": "A pathologist is examining a sample from a patient with amyloidosis. Which of the following is false about the specimen's appearance?",
      "choices": [
        {
          "id": 1,
          "text": "Pink-red color on Congo-red staining"
        },
        {
          "id": 2,
          "text": "Rose pink appearance under crystal violet stain"
        },
        {
          "id": 3,
          "text": "Apple-green birefringence under light microscopy"
        },
        {
          "id": 4,
          "text": "Mahogany brown color on iodine staining"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Amyloid</strong> shows <strong>apple-green birefringence&nbsp;</strong>under <strong>polarised microscopy,</strong> after staining with Congo red.</p>\n<p>The appearance of amyloid:&nbsp;</p>\n<ul>\n<li><strong>Light</strong> microscopy -<strong>&nbsp;</strong><strong>amorphous, eosinophilic, hyaline, extracellular</strong> substance</li>\n<li><strong>Congo red</strong> stain - the characteristic appearance using this stain is due to the <strong>cross-&beta;-pleated sheet</strong> conformation\n<ul>\n<li>Under<strong> ordinary light,</strong>&nbsp;it appears <strong>pink</strong> or red color (as shown below)&nbsp;</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c830681cfff74d1ea88558d3c6f69e70x1280x1078.JPEG\" alt=\"Explanation Image\"><p>- Under<strong>&nbsp;the polarizing microscope -</strong>&nbsp;imparts <strong>apple-green birefringence</strong>&nbsp;to amyloid deposits (as shown in the image below)</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/daea5316aae14b58bd2ef2d0c79acb00x800x573.PNG\" alt=\"Explanation Image\"><ul>\n<li><strong>Electron</strong> microscopy -<strong>&nbsp;</strong>continuous, nonbranching fibrils with a diameter of approximately 7.5 to 10 nm</li>\n<li>X-ray <strong>crystallography</strong> and infrared <strong>spectroscopy</strong> -&nbsp;Characteristic cross-&beta;-pleated sheet conformation.</li>\n</ul>\n<p>It appears <strong>mahogany brown</strong> on <strong>iodine</strong> staining and <strong>rose-pink</strong> on staining with <strong>crystal violet.</strong></p><hr><h3>Related Pearl: Appearance of Amyloid</h3><table>\n<tbody>\n<tr>\n<td><strong>Methods</strong></td>\n<td><strong>Appearance</strong></td>\n</tr>\n<tr>\n<td>On light microscopy and standard tissue stains&nbsp;(H&amp;E)&nbsp;</td>\n<td>Amorphous eosinophilic extracellular substance&nbsp;</td>\n</tr>\n<tr>\n<td>Congo red stain on ordinary light&nbsp;&nbsp;&nbsp;</td>\n<td>Pink or red&nbsp;colour&nbsp;to tissue deposits&nbsp;</td>\n</tr>\n<tr>\n<td>Congo red stain on polarizing microscopy&nbsp;&nbsp;</td>\n<td>Apple-green birefringence&nbsp;</td>\n</tr>\n<tr>\n<td>Fluorescent stains (thioflavin T and S)&nbsp;&nbsp;&nbsp;</td>\n<td>Yellow&nbsp;colour&nbsp;under UV light&nbsp;</td>\n</tr>\n<tr>\n<td>Electron microscopy&nbsp;</td>\n<td>Nonbranching fibrils of indefinite length and a&nbsp;diameter of approximately 7.5 to 10 nm.&nbsp;</td>\n</tr>\n<tr>\n<td>X-ray crystallography and infrared spectroscopy&nbsp;</td>\n<td>Characteristic cross &beta; pleated sheet conformation&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>H&amp;E: Hematoxylin and eosin &nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2488",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not directly involved in graft rejection?",
      "choices": [
        {
          "id": 1,
          "text": "T-Cells"
        },
        {
          "id": 2,
          "text": "Antibodies"
        },
        {
          "id": 3,
          "text": "Macrophages"
        },
        {
          "id": 4,
          "text": "NK cells"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Macrophages present foreign graft antigens to the T-cells but are not directly involved in <strong>graft rejection</strong>.</p>\n<p>Graft rejection<strong>&nbsp;</strong>is both <strong>humoral</strong> and <strong>cell-mediated</strong> in nature. It&nbsp;is a process in which <strong>T-cells</strong> and <strong>antibodies</strong> produced against graft antigens react against tissue grafts and destroy it.</p>\n<p>The major antigenic differences that result in the <strong>rejection</strong> of transplants are differences in <strong>HLA alleles</strong>. The <strong>recipient</strong> <strong>T-cells</strong> are involved in the&nbsp;<strong>recognition </strong>of&nbsp;the <strong>donor MHC</strong> molecules and mount an immune response. Depending on the antigen-presenting cells (APCs) that are involved in T-cell activation, there are 2 pathways:</p>\n<ul>\n<li>Direct pathway of allorecognition - MHC antigens are presented by the <strong>APCs</strong> in the <strong>graft</strong></li>\n<li>Indirect pathway of allorecognition -&nbsp;MHC antigens are presented by&nbsp;the <strong>recipient&rsquo;s</strong> <strong>own</strong> <strong>APCs</strong> (e.g., macrophages)</li>\n</ul>\n<p>The <strong>early activation</strong> of <strong>NK cells</strong> kill allogeneic target cells directly or via antibody-dependent cellular cytotoxicity and release various chemokines and immunomodulatory cytokines.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2331",
      "difficulty": "medium"
    },
    {
      "text": "A man is receiving a matched blood group kidney allograft. While closing the abdomen, the surgeon notices a sudden color change to pale-white in the transplanted kidney. He decides to remove it. Which of the following is responsible for graft rejection in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Preformed antibodies in the recipient"
        },
        {
          "id": 2,
          "text": "Cytotoxic T lymphocyte–mediated injury"
        },
        {
          "id": 3,
          "text": "Tubulointerstitial inflammation due to antibodies"
        },
        {
          "id": 4,
          "text": "Donor antibodies causing endotheliitis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario within minutes of transplant is suggestive of <strong>hyperacute rejection</strong> and is due to <strong>preformed antibodies</strong>&nbsp;from the <strong>recipient.</strong>&nbsp;</p><hr><h3>Related Pearl: Classification of Transplant Rejection Reactions</h3><p><strong>Hyperacute</strong>&nbsp;rejection<strong> (minutes to hours):</strong></p>\n<ul>\n<li class=\"page\" title=\"Page 246\">Mechanism:&nbsp;<strong>Antidonor antibodies</strong> present in the circulation of the recipient</li>\n<li class=\"page\" title=\"Page 246\">Histopathological findings:\n<ul>\n<li>Grossly, cyanotic and mottled graft with pale white areas</li>\n<li>Neutrophils accumulate</li>\n<li>Acute fibrinoid necrosis of vessel walls or complete occlusion by thrombi</li>\n</ul>\n</li>\n</ul>\n<p><strong>Acute</strong>&nbsp;rejection<strong> (days to weeks):</strong></p>\n<ol>\n<li class=\"page\" title=\"Page 246\">Acute<strong> cellular</strong> rejection (acute T cell-mediated rejection):&nbsp;&nbsp;\n<ul>\n<li class=\"page\" title=\"Page 246\">Mechanism:&nbsp;<strong>CD8+ CTLs</strong> directly destroy graft or <strong>CD4+</strong> cells secrete cytokines that damage graft.</li>\n<li class=\"page\" title=\"Page 246\">Histopathological findings:\n<ul>\n<li><strong>Tubulointerstitial pattern (type I):</strong> extensive interstitial and tubular inflammation associated with focal tubular injury</li>\n<li><strong>Vascular pattern </strong>- Inflammation (type II) and necrosis (type III): <strong>Endotheliitis</strong> (swollen endothelial cells with lymphocytes between endothelium and vessel wall)</li>\n</ul>\n</li>\n</ul>\n</li>\n<li>Acute<strong> antibody-mediated</strong> (humoral) rejection:&nbsp;\n<ul>\n<li class=\"page\" title=\"Page 246\">Mechanism: antibodies bind to endothelium and activate complement causing damage and graft failure</li>\n<li class=\"page\" title=\"Page 246\">Histopathological findings:\n<ul>\n<li>Inflammation of glomeruli and peritubular capillaries.</li>\n<li>Activation of the antibody-dependent classical complement pathway.</li>\n<li>Focal thrombosis in small vessels.&nbsp;</li>\n</ul>\n</li>\n</ul>\n</li>\n</ol>\n<p><strong>Chronic</strong>&nbsp;rejection<strong> (months to years):</strong></p>\n<ul>\n<li class=\"page\" title=\"Page 246\">Mechanism:&nbsp;<strong>T-cells</strong> react against alloantigens and secrete cytokines which stimulate <strong>fibroblasts</strong> and <strong>vascular smooth muscle cells</strong> (graft arteriosclerosis). Chronic rejection may also be <strong>antibody-mediated</strong>.</li>\n<li class=\"page\" title=\"Page 246\">Histopathological findings:\n<ul>\n<li>Predominantly vascular changes (intimal thickening and vascular occlusion)</li>\n<li>Glomerulopathy with duplication of basement membrane</li>\n<li>Interstitial fibrosis and tubular atrophy with loss of renal parenchyma</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2334",
      "difficulty": "easy"
    },
    {
      "text": "A patient underwent kidney transplantation due to severe diabetic nephropathy. A few months later, he presented with fever, malaise, and flank pain. During evaluation, oliguria and an acute rise in creatinine levels were observed. A biopsy of the kidney showed endotheliitis. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Acute cell-mediated graft rejection"
        },
        {
          "id": 2,
          "text": "Acute antibody mediated graft rejection"
        },
        {
          "id": 3,
          "text": "Chronic graft rejection"
        },
        {
          "id": 4,
          "text": "Graft vs host disease"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical history and the biopsy findings of <strong>endotheliitis</strong> suggest a diagnosis of <strong>acute cell-mediated graft rejection.</strong></p>\n<p>In acute cell-mediated graft rejection, <strong>CD8+ CTLs</strong> directly destroy graft cells or <strong>CD4+ cells</strong> secrete cytokines that damage the graft.</p>\n<p>On histopathology, it produces two different patterns of injury in the graft:</p>\n<ul>\n<li aria-level=\"1\"><strong>Tubulointerstitial pattern</strong> (type I): extensive interstitial and tubular inflammation associated with focal tubular injury</li>\n<li aria-level=\"1\"><strong>Vascular pattern</strong> - Inflammation (type II) and necrosis (type III),&nbsp;<strong>endotheliitis</strong> (swollen endothelial cells with lymphocytes between endothelium and vessel wall)</li>\n</ul><p><strong>Immunosuppressive therapy</strong>&nbsp;aims to prevent and reduce acute rejection by blocking the activation of alloreactive T cells. In the absence of humoral rejection, patients respond well to immunosuppressive therapy.&nbsp;</p><hr><h3>Related Pearl: Classification of Transplant Rejection Reactions</h3><p><strong>Hyperacute</strong>&nbsp;rejection<strong> (minutes to hours):</strong></p>\n<ul>\n<li class=\"page\" title=\"Page 246\">Mechanism:&nbsp;<strong>Antidonor antibodies</strong> present in the circulation of the recipient</li>\n<li class=\"page\" title=\"Page 246\">Histopathological findings:\n<ul>\n<li>Grossly, cyanotic and mottled graft with pale white areas</li>\n<li>Neutrophils accumulate</li>\n<li>Acute fibrinoid necrosis of vessel walls or complete occlusion by thrombi</li>\n</ul>\n</li>\n</ul>\n<p><strong>Acute</strong>&nbsp;rejection<strong> (days to weeks):</strong></p>\n<ol>\n<li class=\"page\" title=\"Page 246\">Acute<strong> cellular</strong> rejection (acute T cell-mediated rejection):&nbsp;&nbsp;\n<ul>\n<li class=\"page\" title=\"Page 246\">Mechanism:&nbsp;<strong>CD8+ CTLs</strong> directly destroy graft or <strong>CD4+</strong> cells secrete cytokines that damage graft.</li>\n<li class=\"page\" title=\"Page 246\">Histopathological findings:\n<ul>\n<li><strong>Tubulointerstitial pattern (type I):</strong> extensive interstitial and tubular inflammation associated with focal tubular injury</li>\n<li><strong>Vascular pattern </strong>- Inflammation (type II) and necrosis (type III): <strong>Endotheliitis</strong> (swollen endothelial cells with lymphocytes between endothelium and vessel wall)</li>\n</ul>\n</li>\n</ul>\n</li>\n<li>Acute<strong> antibody-mediated</strong> (humoral) rejection:&nbsp;\n<ul>\n<li class=\"page\" title=\"Page 246\">Mechanism: antibodies bind to endothelium and activate complement causing damage and graft failure</li>\n<li class=\"page\" title=\"Page 246\">Histopathological findings:\n<ul>\n<li>Inflammation of glomeruli and peritubular capillaries.</li>\n<li>Activation of the antibody-dependent classical complement pathway.</li>\n<li>Focal thrombosis in small vessels.&nbsp;</li>\n</ul>\n</li>\n</ul>\n</li>\n</ol>\n<p><strong>Chronic</strong>&nbsp;rejection<strong> (months to years):</strong></p>\n<ul>\n<li class=\"page\" title=\"Page 246\">Mechanism:&nbsp;<strong>T-cells</strong> react against alloantigens and secrete cytokines which stimulate <strong>fibroblasts</strong> and <strong>vascular smooth muscle cells</strong> (graft arteriosclerosis). Chronic rejection may also be <strong>antibody-mediated</strong>.</li>\n<li class=\"page\" title=\"Page 246\">Histopathological findings:\n<ul>\n<li>Predominantly vascular changes (intimal thickening and vascular occlusion)</li>\n<li>Glomerulopathy with duplication of basement membrane</li>\n<li>Interstitial fibrosis and tubular atrophy with loss of renal parenchyma</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2740",
      "difficulty": "medium"
    },
    {
      "text": "In patients with acute graft-versus-host disease, which of the following organs is least likely to be involved?",
      "choices": [
        {
          "id": 1,
          "text": "Skin"
        },
        {
          "id": 2,
          "text": "GIT"
        },
        {
          "id": 3,
          "text": "Liver"
        },
        {
          "id": 4,
          "text": "Lung"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The lung is least likely to get affected in <strong>acute graft-versus-host disease</strong>&nbsp;(GVHD).</p>\n<p>GVHD&nbsp;occurs when immunologically competent cells or their precursors are transplanted into immunologically crippled recipients. The transferred cells recognize alloantigens in the host and attack host tissues.</p>\n<p>It is seen <strong>most commonly</strong> in the setting of hematopoietic stem cell (<strong>HSC</strong>) <strong>transplantation.</strong>&nbsp;Rarely, it may occur following transplantation of solid organs rich in lymphoid cells (e.g., the liver) or transfusion of <strong>unirradiated blood.</strong>&nbsp;</p>\n<p>It is of two types, acute and chronic.</p>\n<p><strong>Acute GVHD&nbsp;</strong>develops within <strong>days to weeks</strong><strong>.&nbsp;</strong>There is the involvement of the <strong>immune system</strong> and <strong>epithelium</strong>&nbsp;of the skin, liver, and intestines. It presents with:</p>\n<ul>\n<li>Generalized rash</li>\n<li>Jaundice</li>\n<li>Bloody diarrhea due to mucosal ulceration</li>\n<li>Non-infectious pulmonary infiltrates (rarely), the outcome is generally poor</li>\n</ul>\n<p><strong>Chronic GVHD&nbsp;</strong>may follow the acute syndrome or occur insidiously. It presents with:</p>\n<ul>\n<li>Skin -&nbsp;extensive<strong> cutaneous injury,</strong> with the destruction of skin appendages and dermal fibrosis (may resemble <strong>systemic sclerosis)</strong></li>\n<li>Liver<strong> - chronic liver disease,</strong> manifested as cholestatic jaundice</li>\n<li>GIT - <strong>esophageal strictures</strong></li>\n<li><strong>Immune system</strong> involvement - involution of the thymus and depletion of lymphocytes</li>\n</ul>\n<p>GVHD is <strong>mediated by T lymphocytes</strong> contained in the transplanted <strong>donor cells.&nbsp;</strong>Therefore,&nbsp;depletion of donor T cells before transfusion virtually eliminates the disease.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2335",
      "difficulty": "medium"
    },
    {
      "text": "Graft from identical twin is called:",
      "choices": [
        {
          "id": 1,
          "text": "Allograft"
        },
        {
          "id": 2,
          "text": "Autograft"
        },
        {
          "id": 3,
          "text": "Isograft"
        },
        {
          "id": 4,
          "text": "Xenograft"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>A graft from an<strong> identical twin</strong> is called an&nbsp;<strong>isograft</strong>.</p>\n<p><strong>Isograft</strong> is defined as an organ or tissue that is taken from a donor and is transplanted to a recipient who has the <strong>same genetic constitution</strong> as the donor. For example, graft between<strong> identical twins.</strong></p><hr><h3>Related Pearl: Types of transplants</h3><table>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>&nbsp;Definition</strong></td>\n</tr>\n<tr>\n<td><strong>Orthotopic</strong></td>\n<td>\n<p class=\"p1\">Organ implanted in the same anatomic location in the recipient as it was in the donor.&nbsp;Diseased organ is removed. Eg: heart, lung, liver, intestine</p>\n</td>\n</tr>\n<tr>\n<td><strong>Heterotopic</strong></td>\n<td>\n<p class=\"p1\">Organ implanted in a different anatomic location. Diseased organ is left in place. Eg: Kidney, pancreas</p>\n</td>\n</tr>\n<tr>\n<td><strong>Auxiliary transplantation</strong></td>\n<td>Partial tissue from the donor is used which acts as temporary support for the recipient's injured organ, which remains in place. Eg: left lobe of liver</td>\n</tr>\n<tr>\n<td><strong>Autotransplant&nbsp;</strong></td>\n<td>Transfer of cells/tissues/organs within the same person.&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Allotransplant</strong></td>\n<td>Transfer of cells/tissues/organs within the same species.&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Xenotransplant</strong></td>\n<td>Transfer of cells/tissues/organs in a different species.</td>\n</tr>\n<tr>\n<td><strong>Isograft</strong></td>\n<td>Transfer of organ or tissue within genetically identical individuals. Eg: Identical twins</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0594",
      "difficulty": "easy"
    }
  ]
}